Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riboflavin for Sports Related Concussion
NCT02235337Completed
- Sponsor
- University of Virginia
- Start
- Sep 2014
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label, single-arm trial of riboflavin in concussion (mTBI), sponsored by University of Virginia. Primary endpoint: Time to return to full participation in sports after a sports related concussion at 21 days. Started Sep 2014; status: completed.
02
Drugs
riboflavin
03
Conditions
concussion (mTBI)
Beyond the preview
Go deeper on NCT02235337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235337.